Advertisement
CVS vs MOH
Which Stock Would AI Choose? CVS Health (CVS) vs. Molina Healthcare (MOH) Stock Comparison
Key Takeaways
- CVS has gained approximately 13% over the recent month amid regulatory tailwinds boosting visibility for its Aetna insurance and PBM (pharmacy benefit manager) operations.
- MOH has surged over 34% in the same period, driven by a Q1 earnings beat and reaffirmed guidance.
- Year-to-date, MOH leads with 11% returns compared to CVS's 5%, reflecting stronger momentum in managed care.
- CVS boasts a larger market cap of $105 billion versus MOH's $10 billion, offering greater scale and diversification.
- Both stocks trade at elevated P/E ratios above 50 TTM, signaling market expectations for healthcare sector recovery.
- Recent catalysts position MOH for continued upside from higher 2027 Medicare Advantage rates.
Introduction
In the evolving healthcare landscape, CVS Health and Molina Healthcare (MOH) offer contrasting investment profiles. CVS, a diversified giant spanning retail pharmacy, PBM services, and health insurance via Aetna, contrasts with MOH's specialization in managed care for Medicaid and Medicare populations. This comparison aids investors navigating sector headwinds like regulatory changes and reimbursement pressures, while traders assess relative performance amid recent earnings cycles and market volatility. Key metrics reveal trade-offs in scale, momentum, and risk exposure.
CVS Overview and Recent Performance
CVS Health operates an integrated model with roughly 9,000 retail locations, PBM services processing billions of claims annually, and insurance for 27 million medical members. Recent market activity has seen shares rise about 13% over the past month, trading near $82 with a 52-week range of $58-$85. Sentiment has improved on regulatory tailwinds enhancing Aetna and PBM prospects, including Medicare adjustments providing a $13 billion reprieve. Year-to-date gains stand at 5%, with Q1 earnings due soon amid expectations for Health Services strength. Broader pressures from retail pharmacy margins persist, but diversified revenue supports stability.
MOH Overview and Recent Performance
Molina Healthcare (MOH) focuses on managed care services for low-income families via Medicaid, Medicare, and marketplaces. Shares have climbed over 34% in recent weeks to around $193, within a volatile 52-week range of $121-$333. A Q1 earnings beat—$2.35 adjusted EPS versus $1.94 expected, on $10.8 billion revenue—sparked a 17% surge, alongside reaffirmed full-year guidance and an exit from Medicare Part D. Year-to-date returns reach 11%, fueled by higher 2027 Medicare Advantage rates and stakeholder interest. Medicaid redeterminations pose risks, yet specialized exposure drives outperformance.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the top performers from over 350 AI trading bots that analyze thousands of tickers across stocks, ETFs, and crypto. Only the most suitable for current conditions—based on AI-driven signals, risk management, and market trends—earn a spot among the featured 25 bots. These showcase impressive stats like annualized returns up to 163%, win rates ranging 50-88%, profit factors from 1.5 to 7+, and average trade durations from hours to weeks. Strategies vary widely: short-term scalpers (5-60 minutes) using TP/SL corridors (e.g., 3%/2%), swing traders with fundamental analysis, or multi-agent systems targeting sectors like semiconductors, data centers, and industrials. Traders can copy these bots for diverse styles and timeframes. Visit Trending AI Robots to explore performance details and potential fits for healthcare plays.
Head-to-Head Comparison
CVS and MOH both navigate healthcare regulations but differ in models: CVS's vertical integration spans retail, PBM, and insurance for broad revenue, while MOH targets government programs for higher margins yet concentrated risk. Growth drivers include MOH's Medicaid expansion versus CVS's services segment. Recent momentum favors MOH (34% vs. 13% monthly), but CVS offers lower volatility and scale. Risks encompass reimbursement cuts for both, with MOH more exposed to redeterminations. Market sentiment tilts positive on earnings beats and policy wins, positioning MOH for growth trades and CVS for value stability.
Tickeron AI Verdict
Tickeron’s AI currently leans toward MOH, citing superior recent trend consistency with 34% monthly gains, a Q1 earnings beat, and catalysts like elevated Medicare Advantage rates. While CVS provides stability and diversification, MOH's relative momentum and positioning suggest higher near-term probability of outperformance amid healthcare recovery.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVS is a Buy and MOH is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 3 FA rating(s) are green whileMOH’s FA Score has 1 green FA rating(s).
- CVS’s FA Score: 3 green, 2 red.
- MOH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVS’s TA Score shows that 4 TA indicator(s) are bullish while MOH’s TA Score has 4 bullish TA indicator(s).
- CVS’s TA Score: 4 bullish, 4 bearish.
- MOH’s TA Score: 4 bullish, 5 bearish.
Price Growth
CVS (@Managed Health Care) experienced а +0.62% price change this week, while MOH (@Managed Health Care) price change was -2.20% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.72%. For the same industry, the average monthly price growth was +14.43%, and the average quarterly price growth was +37.57%.
Reported Earning Dates
CVS is expected to report earnings on Aug 05, 2026.
MOH is expected to report earnings on Jul 22, 2026.
Industries' Descriptions
@Managed Health Care (+0.72% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CVS | MOH | CVS / MOH | |
| Capitalization | 130B | 10.2B | 1,275% |
| EBITDA | 11.1B | 617M | 1,799% |
| Gain YTD | 29.826 | 13.761 | 217% |
| P/E Ratio | 44.43 | 52.93 | 84% |
| Revenue | 408B | 45.1B | 905% |
| Total Cash | 11.8B | 9.25B | 128% |
| Total Debt | 78.3B | 3.95B | 1,984% |
CVS | MOH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 71 | 100 | |
SMR RATING 1..100 | 89 | 87 | |
PRICE GROWTH RATING 1..100 | 13 | 46 | |
P/E GROWTH RATING 1..100 | 6 | 4 | |
SEASONALITY SCORE 1..100 | 50 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (4) in the Drugstore Chains industry is significantly better than the same rating for MOH (77) in the Managed Health Care industry. This means that CVS’s stock grew significantly faster than MOH’s over the last 12 months.
CVS's Profit vs Risk Rating (71) in the Drugstore Chains industry is in the same range as MOH (100) in the Managed Health Care industry. This means that CVS’s stock grew similarly to MOH’s over the last 12 months.
MOH's SMR Rating (87) in the Managed Health Care industry is in the same range as CVS (89) in the Drugstore Chains industry. This means that MOH’s stock grew similarly to CVS’s over the last 12 months.
CVS's Price Growth Rating (13) in the Drugstore Chains industry is somewhat better than the same rating for MOH (46) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than MOH’s over the last 12 months.
MOH's P/E Growth Rating (4) in the Managed Health Care industry is in the same range as CVS (6) in the Drugstore Chains industry. This means that MOH’s stock grew similarly to CVS’s over the last 12 months.
| CVS | MOH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 60% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 63% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 71% |
| Advances ODDS (%) | 12 days ago 66% | 9 days ago 67% |
| Declines ODDS (%) | 6 days ago 59% | 6 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 62% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 70% | 6 days ago 68% |
Advertisement
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with UNH. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then UNH could also see price increases.
MOH and
Correlation & Price change
A.I.dvisor indicates that over the last year, MOH has been loosely correlated with CNC. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MOH jumps, then CNC could also see price increases.